Works matching IS 01676997 AND DT 2008 AND VI 26 AND IP 6

Results: 9

Modulation of key signal transduction molecules by a novel peptide combination effective for the treatment of gastrointestinal carcinomas.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 505, doi. 10.1007/s10637-008-9119-2

By:

Singh, Anu;
Jaggi, Manu;
Prasad, Sudhanand;
Dutt, Sarjana;
Singh, Gurvinder;
Datta, Kakali;
Rajendran, Praveen;
Sanna, Vinod;
Mukherjee, Rama;
Burman, Anand

Publication type:

Article

Anticancer activity of a peptide combination in gastrointestinal cancers targeting multiple neuropeptide receptors.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 489, doi. 10.1007/s10637-008-9117-4

By:

Jaggi, Manu;
Prasad, Sudhanand;
Singh, Anu;
Praveen, R.;
Dutt, Sarjana;
Mathur, Archana;
Sharma, Rajan;
Gupta, Neena;
Ahuja, Rinku;
Mukherjee, Rama;
Burman, Anand

Publication type:

Article

Optimal modeling for phase I design of a two drug combination—results of a phase I study of cisplatin with 9-nitrocamptothecin.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 541, doi. 10.1007/s10637-008-9147-y

By:

Lee, S.-J.;
Gounder, M.;
Rubin, E.;
Li, Jong;
Gu, Zheming;
Thalasila, A.;
Loyer, E.;
Kudelka, A.;
Verschraegen, C.

Publication type:

Article

Phase Ι trial of weekly Docetaxel and daily Temozolomide in patients with metastatic disease.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 553, doi. 10.1007/s10637-008-9153-0

By:

Tamaskar, I.;
Mekhail, T.;
Dreicer, R.;
Olencki, T.;
Roman, S.;
Elson, P.;
Bukowski, R.

Publication type:

Article

Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 567, doi. 10.1007/s10637-008-9171-y

By:

Topuz, E.;
Derin, D.;
Can, G.;
Kürklü, E.;
Çınar, S.;
Aykan, F.;
Çevikbaş, A.;
Dişçi, R.;
Durna, Z.;
Şakar, B.;
Saglam, S.;
Tanyeri, H.;
Deniz, G.;
Gürer, Ü.;
Taş, F.;
Guney, N.;
Aydıner, A.

Publication type:

Article

Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 525, doi. 10.1007/s10637-008-9121-8

By:

Li, Xiao-lei;
Liu, Jun-yan;
Lu, Rong;
Xu, Qiong;
Zhu, Zhi-feng;
Wang, Li;
Zhou, Chun-lei;
Jia, Jing;
Fu, Zheng;
Yao, Zhi

Publication type:

Article

CPT21, a novel compound with anti-proliferative effect against gastric cancer cell SGC7901.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 517, doi. 10.1007/s10637-008-9120-9

By:

Zhang, Bo;
Luo, Yu;
Weng, Qinjie;
He, Qiaojun;
Lu, Wei;
Yang, Bo

Publication type:

Article

Aberrant crypt foci and AgNORs as putative biomarkers to evaluate the chemopreventive efficacy of pronyl-lysine in rat colon carcinogenesis.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 531, doi. 10.1007/s10637-008-9122-7

By:

Panneer Selvam, Jayabal;
Aranganathan, Selvaraj;
Nalini, Namasivayam

Publication type:

Article

O-Mel-Inib: A Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose Imatinib mesylate in metastatic uveal melanoma.

Published in:

Investigational New Drugs, 2008, v. 26, n. 6, p. 561, doi. 10.1007/s10637-008-9143-2

By:

Penel, Nicolas;
Delcambre, Corinne;
Durando, Xavier;
Clisant, Stéphanie;
Hebbar, Mohamed;
Negrier, Sylvie;
Fournier, Charles;
Isambert, Nicolas;
Mascarelli, Frédéric;
Mouriaux, Frédéric

Publication type:

Article